Michelle L. Mauermann, M.D.

Closed for Enrollment

• Prospective, Non-interventional, Long-term, Multinational Cohort Safety Study of Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (hATTR-PN) Rochester, Minn.

  The purpose of this study with the Health Authorities from the United States (US), Canada and Europe, is to collect long-term safety information (including any potential side effects) for the drug TEGSEDI in patients with hATTR-PN under real-world conditions.

   

• The Validation of the CAP-PRI (Chronic Acquired Polyneuropathy-Patient Reported Index) in Patients with Acquired and Idiopathic Polyneuropathy Rochester, Minn.

  The primary objective of this study is to validate the chronic acquired polyneuropathy-patient reported index (CAP-PRI) in subjects with acquired and idiopathic polyneuropathy.